Special Issue "Current Research on the Cytotoxicity of Drugs to Humans and Animals"
Deadline for manuscript submissions: 31 December 2021.
Interests: lipid nanoparticles; drug delivery and targeting; nanotoxicology and nanosafety; pharmaceutical chemistry; cosmetics; nanomedicine; clinical trials
Research on the prevention and treatment of several chronic diseases is constantly growing worldwide. In recent years, there has been a rapid increase in the design and development of new drugs for human and animal use. In order to ensure the highest standards of treatment, in vitro cytotoxic assays and in vivo toxicological studies are required to ensure the safety of a drug formulation.
The chronic use of drugs with immunosuppressive and cytotoxic effects may break down organs such as kidneys, stomach, liver, and intestines, causing side effects that are sometimes life-threatening. Furthermore, antineoplastic drugs (known for their cytotoxic activity) from different sources and with different mechanisms of action are commonly used in large doses.
This Special Issue aims to cover the current research in human and veterinary medicine focused on the cytotoxicity of drugs, and expects to receive contributions describing the recent advances and technological challenges encountered in new approaches to reduce adverse side effects of such drugs. Research and review papers on the safe use of drugs, and the potential risk of side effects in humans and animals, are also welcome.
Dr. Aleksandra Zielinska
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cytotoxicity assay
- immunosuppressive drugs
- cytostatic/antineoplastic drugs
- side effects
- clinical trials
- in vitro and in vivo studies
- breakthrough treatment of diseases in humans and animals